CN1686174A - Tumour inhibitor formula for preventing and treating malignant tumour - Google Patents
Tumour inhibitor formula for preventing and treating malignant tumour Download PDFInfo
- Publication number
- CN1686174A CN1686174A CNA2005100644669A CN200510064466A CN1686174A CN 1686174 A CN1686174 A CN 1686174A CN A2005100644669 A CNA2005100644669 A CN A2005100644669A CN 200510064466 A CN200510064466 A CN 200510064466A CN 1686174 A CN1686174 A CN 1686174A
- Authority
- CN
- China
- Prior art keywords
- cell
- tumour
- malignant
- preventing
- abscisic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
A tumor-suppressing medicine 'Yiliusu' for preventing and treating cancers is proportionally prepared from bioactive ox liver powder and VA. It features that said bioactive ox liver powder and VA can be used to synthesize abscisic acid under the action of stomach.
Description
Technical field
The present invention relates to the tumour medicine field.
Background technology
The malignant tumor traditional treatment according to put, amic therapy method, to be one with the health therapy start with from suppressing the malignant cell division tumour inhibitor, thereby suppress developing of malignant tumor.
Summary of the invention
The objective of the invention is for suppressing developing of this disease of malignant tumor, special research and development tumour inhibitor.
Technical scheme of the present invention is that the Hepar Bovis seu Bubali lyophilization of virus-free health is ground into end and vitamin A, and by Hepar Bovis seu Bubali: the mixed of vitamin A=1.5: 1 becomes powder, just is tumour inhibitor.
The invention has the beneficial effects as follows, after taking this medicine, in stomach, pass through contained xanthine oxidase and the tryrosinase of the bioactive Hepar Bovis seu Bubali of tool, vitamin A is converted into abscisic acid, abscisic acid can suppress the elongation of cell, the proper splitting of pair cell is like water off a duck's back, and the division of malignant cell is to elongate to all around earlier to carry out mitosis at double again.Preventing and treating the state of an illness by the fission process of abscisic acid inhibition malignant cell develops.
The specific embodiment
Prevent and treat the medicine of malignant tumor, tumour inhibitor uses special-effect.Per diem taking the dosage of 250mgX3 takes.Can suppress developing of malignant cell to the fission process inhibitory action of malignant cell.
In 1.5: 1 mixed forming of ratio, malignant tumor patient was because the detoxifcation secretion of bile has been lost the ability that vitamin A is changed into abscisic acid by the bioactive material Hepar Bovis seu Bubali of tool powder (lyophilization obtains) and vitamin A.Tumour inhibitor is characterised in that, takes the back and pass through the contained xanthine oxidase of Hepar Bovis seu Bubali powder and the effect of tryrosinase in stomach, and vitamin A directly changes into abscisic acid, and abscisic acid can suppress the elongation of cell, and the pair cell proper splitting is had no effect.The division characteristics of malignant cell are to elongate to all around earlier to carry out mitosis again, and malignant cell is bigger than normal cell volume, and division is multiplied soon.This material tumour inhibitor that can produce abscisic acid divides malignant cell, plays inhibitory action.
Claims (2)
1. tumour inhibitor prescription of preventing and treating malignant tumor, it is characterized in that, the generation medicine that can suppress malignant cell to the fission process inhibitory action of malignant cell, by tool bioactive material Hepar Bovis seu Bubali powder and vitamin A in 1.5: 1 mixed forming of ratio.
2. the tumour inhibitor prescription of preventing and treating malignant tumor according to claim 1 is characterized in that, take tumour inhibitor after, in stomach, by the contained xanthine oxidase of Hepar Bovis seu Bubali powder and the effect of tryrosinase, vitamin A directly becomes abscisic acid, and abscisic acid can suppress the elongation of cell, the pair cell proper splitting is had no effect, the division characteristics of dislike giving birth to the tumor cancerous cell be earlier to around elongate, carry out mitosis again, malignant tumor is carefully big than normal cell volume, division is fast, is multiplied.This inhibition that can produce the material tumour inhibitor of abscisic acid to malignant cell mitosis process has suppressed the division of malignant tumor cancerous cell, plays preventive and therapeutic effect.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2005100644669A CN1686174A (en) | 2005-04-18 | 2005-04-18 | Tumour inhibitor formula for preventing and treating malignant tumour |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2005100644669A CN1686174A (en) | 2005-04-18 | 2005-04-18 | Tumour inhibitor formula for preventing and treating malignant tumour |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1686174A true CN1686174A (en) | 2005-10-26 |
Family
ID=35304216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2005100644669A Pending CN1686174A (en) | 2005-04-18 | 2005-04-18 | Tumour inhibitor formula for preventing and treating malignant tumour |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1686174A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8389024B2 (en) | 2005-06-22 | 2013-03-05 | Gonzalo Romero M. | Abscisic acid against cancer |
| CN111494353A (en) * | 2010-09-17 | 2020-08-07 | 美商华仑生物科学公司 | Pharmaceutical and nutraceutical compositions of abscisic acid |
-
2005
- 2005-04-18 CN CNA2005100644669A patent/CN1686174A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8389024B2 (en) | 2005-06-22 | 2013-03-05 | Gonzalo Romero M. | Abscisic acid against cancer |
| CN111494353A (en) * | 2010-09-17 | 2020-08-07 | 美商华仑生物科学公司 | Pharmaceutical and nutraceutical compositions of abscisic acid |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0414455A (en) | Methods for Using Regenerative Cells to Treat Peripheral Vascular Disease and Related Disorders | |
| CN103446308A (en) | Traditional Chinese medicine for treating sole callus | |
| RU2463811C1 (en) | Specialised product for sportspeople alimentation | |
| CN104382005A (en) | Glucosamine chondroitin collagen tablet and preparation method thereof | |
| CN103877247B (en) | Medicine being used for the treatment of decubital ulcer and preparation method thereof | |
| US20040086581A1 (en) | Bio-energetic joint and arthritis pain formula | |
| CN1686174A (en) | Tumour inhibitor formula for preventing and treating malignant tumour | |
| CN104887958B (en) | Treat Chinese medicine preparation of Shelled Turtle Trionyx Sinensis enteritis and preparation method thereof | |
| CN114745968A (en) | Diamond cherry mixture-a dietary supplement ingredient based on a mixture of biomass containing cherries, tart cherries or cherry blossom and natural antioxidants | |
| CN100402074C (en) | A Chinese medicinal ointment for promoting wound healing after anal fistula operation and preparation method thereof | |
| WO2016043668A1 (en) | A composition suitable for vegetarians providing calcium supplementation as well as gout prevention and treatment and the method of preparation thereof | |
| RU2601624C1 (en) | Agent possessing general strengthening and antioxidant action | |
| CN104382148A (en) | Fruit and vegetable drink beneficial to improving male vigour | |
| CN104435544A (en) | Traditional Chinese medicine oral liquid for treating leukemia through being cooperated with chemotherapy and preparation method thereof | |
| CN1259087C (en) | Medicine for treating trauma and sores and its preparing process | |
| WO2017082849A1 (en) | Macaroni comprising vegetable additives | |
| CN104547150A (en) | Application of inflammation-diminishing and pain-relieving external medicine as oral agent for treating tumors and ulcerative carbuncles | |
| CN104000919A (en) | Traditional Chinese medicine composition | |
| CN107927763A (en) | A kind of marine low temperature SOD health products of anti-aging | |
| CN102008072B (en) | Blood pressure lowering edible wild herb food therapy composition | |
| Shafi | GREEN BLOOD THERAPY IN MODERN MEDICINE. | |
| CN106728505A (en) | A kind of Chinese medicine composition for treating pig founder | |
| US20200068936A1 (en) | Linexus composition | |
| CN101347459B (en) | Medicine for treating cancer | |
| CN101317860A (en) | Honeybee extract liquid coughremedy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |